The Indian government banned the export of hydroxychloroquine and formulations made from the medication, as experts test the efficacy of the drug in helping treat patients infected with COVID-19.

India’s drugs regulator asked all states to enforce a court directive prohibiting online medicine sales, a senior government official said, raising industry concerns of potential disruption of some online businesses.

Novartis AG won U.S. approval for the company’s experimental sickle cell disease drug Adakveo.

Mylan has come under fire from the U.S. Food and Drug Administration over inadequate good manufacturing practices at one of the company’s drug manufacturing facilities in India.

India’s ability to produce affordable generic drugs has led to the country’s reputation of being the “pharmacy of the world,” according to Dr. Reddy’s Vice President Radha Iyer.

India banned the sale of electronic cigarettes and warned of an “epidemic” among young people, in the latest and potentially biggest move globally against vaping over growing health concerns.

Indian doctors removed a tumor with a record number of 526 teeth inside a seven-year-old boy’s mouth, the medical team in the southern city of Chennai said.

Alameda, Calif.-based Exelixis inked a collaboration, option and license deal with India’s Aurigene Discovery Technologies Ltd., which focuses on oncology and inflammatory diseases.

Johnson & Johnson’s baby shampoo samples failed quality tests conducted by the northwestern Indian state of Rajasthan, according to a public notice from the state’s drugs watchdog, findings that were rejected by the U.S. drugmaker.

A global coalition set up to fight emerging epidemics struck a $31 million deal with scientists at Japan’s University of Tokyo to speed up work on a vaccine against a brain-damaging disease caused by the Nipah virus.